APA (7th ed.) Citation

Dokukina, T. V., Makhrov, M. V., Gaidukevich, I. V., Gilep, A. A., Golubeva, T. S., Khlebokazov, F. P., . . . Korolevich, P. P. (2016). OPPORTUNITIES TO OPTIMIZE ANTIEPILEPTIC THERAPY WITH USE OF PHARMACOGENETIC BIOMARKERS. IRBIS LLC.

Chicago Style (17th ed.) Citation

Dokukina, T. V., M. V. Makhrov, I. V. Gaidukevich, A. A. Gilep, T. S. Golubeva, F. P. Khlebokazov, N. N. Misyuk, and P. P. Korolevich. OPPORTUNITIES TO OPTIMIZE ANTIEPILEPTIC THERAPY WITH USE OF PHARMACOGENETIC BIOMARKERS. IRBIS LLC, 2016.

MLA (9th ed.) Citation

Dokukina, T. V., et al. OPPORTUNITIES TO OPTIMIZE ANTIEPILEPTIC THERAPY WITH USE OF PHARMACOGENETIC BIOMARKERS. IRBIS LLC, 2016.